PMID- 7509623 OWN - NLM STAT- MEDLINE DCOM- 19940407 LR - 20211109 IS - 1045-2257 (Print) IS - 1045-2257 (Linking) VI - 8 IP - 3 DP - 1993 Nov TI - Carcinogen-induced amplification of SV40 DNA inserted at 9q12-21.1 associated with chromosome breakage, deletions, and translocations in human uroepithelial cell transformation in vitro. PG - 155-66 AB - The fate of integrated SV40 viral genome in SV40-immortalized human uroepithelial cells (SV-HUC) during multistep chemical transformation in vitro was studied. We previously reported that exposure of SV-HUC at passage (P) 15 to the chemical carcinogens 3-methylcholanthrene (MCA), 4-aminobiphenyl (ABP), or the N-hydroxy metabolites of ABP causes tumorigenic transformation and/or neoplastic progression. We report now that these same chemical carcinogens induce amplification of SV40 DNA in SV-HUC. We used fluorescence in situ hybridization (FISH) to show that this amplification occurs at the SV40 integration site, which was mapped near a common fragile site at 9q12-21.1 on the der(9)t(8;9) chromosome that is present in all SV-HUC at the earliest passage studied. Karyotypic analysis, along with FISH, also revealed that all carcinogen-induced tumors (T-SV-HUCs) had breaks at 9q12-21.1, deletions of 9q12-21.1-->pter, and new derivative chromosomes containing SV40 in the segment 9q12-21.1-->9q34::8q22-->8qter. Southern blot analysis, along with FISH, confirmed SV40 genome rearrangements in T-SV-HUCs. In contrast, no 9q12-21.1 breaks were observed in control SV-HUC. Thus, these results associate 9q12-21.1-->pter alterations with HUC tumorigenic transformation. In addition, these results indicate for the first time that (carcinogen-induced) amplification of chromosome-integrated viral genes may create sites that are prone to breakage, deletions, and translocations. These results suggest a new mechanism by which chemical carcinogens in synergy with a DNA tumor virus could initiate a cascade of events that contribute to the genomic instability associated with tumorigenesis. FAU - Kao, C AU - Kao C AD - University of Wisconsin Comprehensive Clinical Cancer Center, Department of Human Oncology, Madison 53792. FAU - Wu, S Q AU - Wu SQ FAU - DeVries, S AU - DeVries S FAU - Reznikoff, W S AU - Reznikoff WS FAU - Waldman, F M AU - Waldman FM FAU - Reznikoff, C A AU - Reznikoff CA LA - eng GR - NCI RO1-CA29525/CA/NCI NIH HHS/United States GR - P01-CA519871/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Genes Chromosomes Cancer JT - Genes, chromosomes & cancer JID - 9007329 RN - 0 (Carcinogens) RN - 0 (DNA, Viral) SB - IM MH - Carcinogens/*pharmacology MH - Cell Line, Transformed MH - Cell Transformation, Neoplastic/*drug effects MH - *Chromosome Aberrations MH - Chromosome Deletion MH - Chromosome Mapping MH - Chromosomes, Human, 6-12 and X MH - *Chromosomes, Human, Pair 9 MH - DNA, Viral/analysis MH - Gene Amplification/*drug effects MH - Gene Expression Regulation, Neoplastic/genetics MH - Gene Rearrangement MH - Genes, Viral/genetics MH - Humans MH - In Situ Hybridization, Fluorescence MH - Molecular Probe Techniques MH - Simian virus 40/drug effects/*genetics MH - Translocation, Genetic MH - Tumor Cells, Cultured MH - Virus Integration EDAT- 1993/11/01 00:00 MHDA- 1993/11/01 00:01 CRDT- 1993/11/01 00:00 PHST- 1993/11/01 00:00 [pubmed] PHST- 1993/11/01 00:01 [medline] PHST- 1993/11/01 00:00 [entrez] AID - 10.1002/gcc.2870080304 [doi] PST - ppublish SO - Genes Chromosomes Cancer. 1993 Nov;8(3):155-66. doi: 10.1002/gcc.2870080304.